Acute Respiratory Distress Syndrome Clinical Trial
Official title:
Immediate Effects of Chest Physiotherapy in Tracheotomized Patients With Acute Respiratory Distress Syndrome.
Positive expiratory pressure (PEP) breathing is common for treatment of different lung
diseases and can increase lung volume and increase elimination of secretion from the airways.
Today there is no evidence whether the treatment is effective or not for patients in the
intensive care unit. The purpose of this study is to evaluate if PEP breathing can increase
oxygenation for patients in the intensive care unit during weaning from the ventilator after
acute respiratory distress syndrome.
PEP breathing will be applied on the tracheal cannula for 15 minutes. Measure of the PEP
effect will be done before, during and for 20 minutes after PEP breathing.
Procedure:
To achieve steady state, all subjects are positioned in a semi-recumbent position (30°) for
60 minutes before the start of the intervention and remain in that position during the entire
investigation. Subjects are instructed to avoid talking and movements during both steady
state and measurements. Airway suctioning (up to 20 kPa) through the tracheal cannula is
performed only if there is risk for tube obstruction or if SpO2 decreases below 90%.
Frequency of airway suctioning, and number of coughs during the study time are registered. An
extra pre-intervention measurement is performed 15 minutes after the first to increase the
validity of baseline measurements and control for changes in measured variables due to
spontaneous variations.
A PEP device consisting of a one-way valve and exchangeable resistance nipples is used during
the PEP breathing treatment. The resistance nipple is chosen at the start of the intervention
aiming at an airway pressure of 10-15 cmH2O during tidal breathing (measured with a
calibrated manometer). The duration of the PEP treatment is 15 minutes. Complementary oxygen
is delivered at the same amount as before the intervention.
Measurements:
The primary outcome is PaO2. Five separate arterial blood samples of 0.7-1.5 ml each
(altogether 3.5-7.5 ml for each subject) are drawn from an existing arterial catheter in the
radial artery in the left or the right arm by nurses at the ward, and directly analysed.
Subject characteristics are registered from the clinical records, including gender, age, body
mass index (BMI), smoking history, duration of invasive ventilation, and length of ICU stay.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Recruiting |
NCT05535543 -
Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
|
||
Completed |
NCT04695392 -
Restore Resilience in Critically Ill Children
|
N/A | |
Terminated |
NCT04972318 -
Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia
|
N/A | |
Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
Completed |
NCT04078984 -
Driving Pressure as a Predictor of Mechanical Ventilation Weaning Time on Post-ARDS Patients in Pressure Support Ventilation.
|
||
Completed |
NCT04451291 -
Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure
|
N/A | |
Not yet recruiting |
NCT06254313 -
The Role of Cxcr4Hi neutrOPhils in InflueNza
|
||
Not yet recruiting |
NCT04798716 -
The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
|
Phase 1/Phase 2 | |
Withdrawn |
NCT04909879 -
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT02881385 -
Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation
|
N/A | |
Terminated |
NCT02867228 -
Noninvasive Estimation of Work of Breathing
|
N/A | |
Completed |
NCT02545621 -
A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
|
||
Completed |
NCT02232841 -
Electrical Impedance Imaging of Patients on Mechanical Ventilation
|
N/A | |
Withdrawn |
NCT02253667 -
Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients
|
N/A | |
Withdrawn |
NCT01927237 -
Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide
|
N/A | |
Completed |
NCT01504893 -
Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia
|
N/A | |
Completed |
NCT02889770 -
Dead Space Monitoring With Volumetric Capnography in ARDS Patients
|
N/A | |
Completed |
NCT02814994 -
Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients
|
N/A | |
Completed |
NCT01680783 -
Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure
|
N/A |